ENLV
Live chart
What they do
Enlivex Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ).
For information only · Important disclosures
Grades vs sector
No sector grades for ENLV yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.
Our models
Not held by any of our 5 live models right now.
News
More newsKey stats
Valuation and fundamentals
Valuation & fundamentals
Earnings
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-09-25 | -0.31 | 97.80 | +31648.4% |
| 2026-03-25 | -0.45 | -1.41 | -212.7% |
| 2025-11-14 | -1.80 | -1.35 | +25.0% |
| 2025-08-29 | -2.40 | -1.20 | +50.0% |
| 2025-05-30 | -2.40 | -2.25 | +6.2% |
| 2025-03-31 | -2.40 | -3.45 | -43.8% |
| 2024-11-29 | -2.40 | -1.80 | +25.0% |
| 2024-08-30 | -1.20 | -2.40 | -100.0% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2025-12-31 | $0 | – |
| 2025-09-30 | $0 | – |
| 2025-06-30 | $0 | – |
| 2025-03-31 | $0 | – |
Rating changes
Third-party analyst actions, not Coteau's views. All rating changes
Stats refreshed 2026-10-21 18:14:55 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Beta 0.9 · Oct 21, 2026